1)  Calcium antagonist
					 
	
					
				
				 
	
					
				钙拮抗药
				1.
					Analysis of calcium antagonist used in guangdong province during the period 2000-2003;
					 
					
						
						 
					
						2000-2003年广东省钙拮抗药用药分析
					2.
					Effects of therapeutic dose of erythromycin in combination with calcium antagonists on gastrointestinal motion in mice and rabbits;
						
						治疗量红霉素与钙拮抗药合用对动物胃肠运动的影响
					
					2)  Calcium antagonists
					 
	
					
				
				 
	
					
				钙拮抗药
				1.
					Results Calcium antagonists consumption rates upward trend,which amlodipine tablets,Glauber local-sustained-release tablets and the controlled-rele.
						
						目的:统计和分析我院钙拮抗药的应用情况,了解这类药物应用的变化情况及发展趋势。
					
					3)  Dihydropyridine calcium antagonist
					 
	
					
				
				 
	
					
				二氢吡啶类钙拮抗药
				1.
					CONCLUSIONS:Dihydropyridine calcium antagonists dominate Guangdong market.
					 
					
						
						 
					
						结论:二氢吡啶类钙拮抗药居广东市场的主导地位。
					
					4)  calcium antagonists
					 
	
					
				
				 
	
					
				钙拮抗剂
				1.
					Neuronic calcium channel and anti-cerebral ischemia effect of calcium antagonists;
					 
					
						
						 
					
						神经元钙通道及钙拮抗剂的抗脑缺血作用
					2.
					Interferential effect of calcium antagonists on cadmium nephrotoxicity;
					 
					
						
						 
					
						钙拮抗剂对染镉肾细胞的干预作用
					3.
					Analysis of ADR associated with calcium antagonists in 166 cases;
					 
					
						
						 
					
						166例常用钙拮抗剂不良反应分析
					
					5)  calcium antagonist
					 
	
					
				
				 
	
					
				钙拮抗剂
				1.
					Protective effects of calcium antagonist on liver in severe acute pancreatitis;
					 
					
						
						 
					
						钙拮抗剂对重症急性胰腺炎肝损伤的保护作用
					2.
					Nursing care of patients with hypothalamus injury treated with mild hypothermia and calcium antagonist;
						
						亚低温联合钙拮抗剂治疗丘脑下部损伤患者的观察
					3.
					The effect of calcium antagonists on day and night rhythmic BP changes in patients with essential hypertension;
						
						钙拮抗剂类药物对原发性高血压患者昼夜节律变化的影响
					
					6)  Calcium-channel blocker
					 
	
					
				
				 
	
					
				钙拮抗剂
				1.
					Methods Calcium-channel blockers(CCBs)as a first-line antihypertensives were used to control blood pressure in 93 patients undergoing renal artery stenting for atherosclerotic renal artery stenosis with target blood pressure as 140/90 mmHg, the blood pressue and renal function during peri-interventional and follow up stage were monitored.
						
						方法93例肾动脉狭窄支架置入术患者,术前术后以钙拮抗剂为首选的降压药物,配合使用血管紧张素转换酶抑制剂(ACEI)及肾上腺素能受体结合剂(ARB)类控制血压。
					补充资料:钙拮抗药
		分子式:
CAS号:
性质: 又称钙通道阻滞药。一类阻滞钙离子经钙通道从细胞外液流入细胞内或在细胞内与Ca2+竞争钙调蛋白的结合部位的药物。钙参与心脏搏动、肌肉收缩、血液凝固、递质释放等许多生理、生化反应。钙拮抗药有广泛的特别是对心血管系统的药理作用,包括对心脏的负性肌力、负性频率和负性传导作用,对冠状、脑血管和外周动脉的舒张作用,抑制血小板聚集作用等。广泛用于心绞痛、心律失常、高血压、脑血管疾病的治疗。常用药有维拉帕米、地尔硫卓、硝苯地平以及氯丙嗪等。
		
		CAS号:
性质: 又称钙通道阻滞药。一类阻滞钙离子经钙通道从细胞外液流入细胞内或在细胞内与Ca2+竞争钙调蛋白的结合部位的药物。钙参与心脏搏动、肌肉收缩、血液凝固、递质释放等许多生理、生化反应。钙拮抗药有广泛的特别是对心血管系统的药理作用,包括对心脏的负性肌力、负性频率和负性传导作用,对冠状、脑血管和外周动脉的舒张作用,抑制血小板聚集作用等。广泛用于心绞痛、心律失常、高血压、脑血管疾病的治疗。常用药有维拉帕米、地尔硫卓、硝苯地平以及氯丙嗪等。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
	参考词条